K788-1337 Screening compound: 6-[(4-methylpiperidin-1-yl)sulfonyl]-N-(1-phenylethyl)-2-(pyridin-3-yl)quinoline-4-carboxamide

K788-1337 Screening compound: 6-[(4-methylpiperidin-1-yl)sulfonyl]-N-(1-phenylethyl)-2-(pyridin-3-yl)quinoline-4-carboxamide
K788-1337 Screening compound: 6-[(4-methylpiperidin-1-yl)sulfonyl]-N-(1-phenylethyl)-2-(pyridin-3-yl)quinoline-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K788-1337
6-[(4-methylpiperidin-1-yl)sulfonyl]-N-(1-phenylethyl)-2-(pyridin-3-yl)quinoline-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K788-1337

Molecular Formula

C29H30N4O3S (C29 H30 N4 O3 S)

Compound Name

6-[(4-methylpiperidin-1-yl)sulfonyl]-N-(1-phenylethyl)-2-(pyridin-3-yl)quinoline-4-carboxamide

IUPAC name

6-[(4-methylpiperidin-1-yl)sulfonyl]-N-(1-phenylethyl)-2-(pyridin-3-yl)quinoline-4-carboxamide

SMILES

CC(c1ccccc1)NC(c1c(cc(cc2)S(N3CCC(C)CC3)(=O)=O)c2nc(-c2cnccc2)c1)=O

InChI

InChI=1S/C29H30N4O3S/c1-20-12-15-33(16-13-20)37(35,36)24-10-11-27-25(17-24)26(18-28(32-27)23-9-6-14-30-19-23)29(34)31-21(2)22-7-4-3-5-8-22/h3-11,14,17-21H,12-13,15-16H2,1-2H3,(H,31,34)/t21-/m0/s1

InChI Key

PXVQGGMWCVVOJC-NRFANRHFSA-N

MDL Number (MFCD)

MFCD15103057

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

514.65

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.136

Distribution Coefficient, logD

5.135

Water Solubility, LogSw

-4.83

Polar Surface Area

73.103

Acid Dissociation Constant (pKa)

13.36

Base Dissociation Constant (pKb)

4.61

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

27.60

K788-1337 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Purinergic Library (3321 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Ion Channels
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K788-1337 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K788-1337?
Check Price and Availability of K788-1337, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K788-1337 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K788-1337
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K788-1337
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K788-1337 available by request